- Home
- OTLY vs NPCE Comparison
OTLY vs NPCE Comparison
Compare OTLY & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLY
- NPCE
- Stock Information
- Founded
- OTLY 1994
- NPCE 1997
- Country
- OTLY Sweden
- NPCE United States
- Employees
- OTLY N/A
- NPCE N/A
- Industry
- OTLY Packaged Foods
- NPCE Medical Specialities
- Sector
- OTLY Consumer Staples
- NPCE Health Care
- Exchange
- OTLY Nasdaq
- NPCE Nasdaq
- Market Cap
- OTLY 303.5M
- NPCE 292.9M
- IPO Year
- OTLY 2021
- NPCE 2021
- Fundamental
- Price
- OTLY $17.79
- NPCE $8.99
- Analyst Decision
- OTLY Buy
- NPCE Strong Buy
- Analyst Count
- OTLY 5
- NPCE 6
- Target Price
- OTLY $19.25
- NPCE $16.67
- AVG Volume (30 Days)
- OTLY 143.0K
- NPCE 205.6K
- Earning Date
- OTLY 07-23-2025
- NPCE 08-12-2025
- Dividend Yield
- OTLY N/A
- NPCE N/A
- EPS Growth
- OTLY N/A
- NPCE N/A
- EPS
- OTLY N/A
- NPCE N/A
- Revenue
- OTLY $828,200,000.00
- NPCE $88,570,000.00
- Revenue This Year
- OTLY $4.68
- NPCE $21.04
- Revenue Next Year
- OTLY $4.78
- NPCE $10.73
- P/E Ratio
- OTLY N/A
- NPCE N/A
- Revenue Growth
- OTLY 4.43
- NPCE 23.32
- 52 Week Low
- OTLY $6.00
- NPCE $5.45
- 52 Week High
- OTLY $20.80
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- OTLY 64.37
- NPCE 48.24
- Support Level
- OTLY $16.90
- NPCE $8.17
- Resistance Level
- OTLY $18.23
- NPCE $8.73
- Average True Range (ATR)
- OTLY 0.93
- NPCE 0.56
- MACD
- OTLY -0.04
- NPCE 0.07
- Stochastic Oscillator
- OTLY 78.27
- NPCE 67.44
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.